QRG Capital Management Inc. Has $1.81 Million Stake in Bath & Body Works, Inc. $BBWI

QRG Capital Management Inc. trimmed its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 1.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,297 shares of the company’s stock after selling 1,081 shares during the period. QRG Capital Management Inc.’s holdings in Bath & Body Works were worth $1,806,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in BBWI. SVB Wealth LLC bought a new position in shares of Bath & Body Works during the first quarter worth approximately $35,000. Geneos Wealth Management Inc. increased its stake in Bath & Body Works by 217.7% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after acquiring an additional 801 shares during the period. Parallel Advisors LLC increased its stake in Bath & Body Works by 63.3% during the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock worth $37,000 after acquiring an additional 481 shares during the period. Golden State Wealth Management LLC increased its stake in Bath & Body Works by 94.7% during the 1st quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after acquiring an additional 642 shares during the period. Finally, UMB Bank n.a. increased its stake in Bath & Body Works by 65.9% during the 1st quarter. UMB Bank n.a. now owns 1,501 shares of the company’s stock worth $46,000 after acquiring an additional 596 shares during the period. Institutional investors own 95.14% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have commented on BBWI shares. Citigroup lowered their price objective on Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research note on Tuesday, August 19th. Wall Street Zen lowered Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Barclays raised their price objective on Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Friday, August 29th. Telsey Advisory Group restated an “outperform” rating and set a $38.00 price objective on shares of Bath & Body Works in a research note on Thursday, August 28th. Finally, UBS Group reduced their target price on Bath & Body Works from $36.00 to $32.00 and set a “neutral” rating on the stock in a report on Friday, August 29th. Eleven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, Bath & Body Works has an average rating of “Moderate Buy” and a consensus target price of $38.15.

Bath & Body Works Stock Down 2.9%

NYSE BBWI opened at $25.67 on Wednesday. Bath & Body Works, Inc. has a twelve month low of $24.93 and a twelve month high of $41.87. The company has a market cap of $5.29 billion, a price-to-earnings ratio of 7.62, a price-to-earnings-growth ratio of 0.90 and a beta of 1.52. The business’s fifty day moving average is $28.22 and its 200 day moving average is $29.41.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings data on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, meeting the consensus estimate of $0.37. Bath & Body Works had a negative return on equity of 48.43% and a net margin of 9.88%.The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter last year, the business posted $0.37 EPS. Bath & Body Works’s revenue for the quarter was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 5th. Investors of record on Friday, August 22nd were issued a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $0.80 annualized dividend and a dividend yield of 3.1%. Bath & Body Works’s dividend payout ratio (DPR) is 23.74%.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.